public access
Dr Maxime Prost
Dr Maxime Prost
France Medical Affairs Director
Stéphane Eifler
Stéphane Eifler
International Medical Affairs Director

It is with a great pleasure that we invite you to read and share this first “Microbiota Newsletter”. Under the auspices of the BMI (Biocodex Microbiota Institute), this document will be released three times a year (two in 2017), it will be available in three languages (English, Spanish and French) and will also be downloadable from the BMI website: The “Microbiota Newsletter” is focused on the importance of the various microbiota. It is intended to be “universal” and will therefore replace the newsletters that were proposed by Biocodex France (“Le Microbiote dans tous ses états”) and by Biocodex International (“Biotascope”).

We are very grateful to the authors of the French and international newsletters - in particular Professors Harry Sokol (Paris) and Emmanuel Mas (Toulouse) and Professor Serhat Bor (Turkey), Editor-in-chief, as well as the members of the ISGOP board. We have decided, as it was the case in the previous formats, to entrust the best world experts with the drafting of the contents.

Several section will be included in this newsletter:

• An overview article: Dr. Pauline Jouët (Boulogne-Billancourt, France) explains the increasingly important role that the gut microbiota could play in the pathophysiology of irritable bowel syndrome in adults and in children.

• An analysis of two recent publications: in the first analysis, Prof. Harry Sokol (Paris, France) discusses the work done by G. de Palma et al. illustrating the changes in intestinal behavior and functions in mice that received fecal microbiota transplantation from adult patients with irritable bowel syndrome. In the second literature analysis, Prof. Emmanuel Mas (Toulouse, France) discusses the results obtained by M. Yassour et al. illustrating the impact of the use of antibiotics on the gut microbiome in infants.

• A review of 4 literature articles: Prof. Ener Dinleyici (Eskisehir, Turkey) discusses the interest that Akkermansia muciniphila could have in obesity and metabolic syndrome, the influence of the delivery mode on microbiota composition in the first 6 months of life, the new mechanisms of action of Saccharomyces boulardii on antibiotic-induced dysbiosis and the criteria defining the quality of a probiotic.

• A selection of the main communications related to the gut microbiota from the latest international congresses of gastroenterology or pediatrics, starting with the Gut Summit that was held in Paris on March 11-12, 2017 for which Dr. Alexis Mosca (Robert Debré Hospital, Paris) proposes a compilation of highlights.

We hope you will enjoy your reading!

Biocodex Microbiota Institute overview

The Biocodex Microbiota Institute: an international leader in microbiota